Alk-Abello ASWBO:ALKB -0.12%66 Operating Margin % is 32.19% as of Mar. 2026, which is 260% above its 10-year median of 8.94. GuruFocus rates WBO:ALKB with a GF Score™ of 66/100 and a GF Value™ of €27.26 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 944 Biotechnology companies, Alk-Abello AS ranks better than 92.06% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. Alk-Abello AS's Operating Income for the
three
months ended in Mar. 2026 was €76.3 Mil. Alk-Abello AS's Revenue for the
three
months ended in Mar. 2026 was €236.9 Mil. Therefore, Alk-Abello AS's Operating Margin % for the quarter that ended in Mar. 2026 was 32.19%.
Good Sign:
Alk-Abello AS operating margin is expanding. Margin expansion is usually a good sign.
The historical rank and industry rank for Alk-Abello AS's Operating Margin % or its related term are showing as below:
WBO:ALKB'
s Operating Margin % Range Over the Past 10 Years
Min: -3.29 Med: 8.94 Max: 26.75
Current: 26.75
WBO:ALKB's Operating Margin % is ranked better than 92.06% of 944
companies
in the Biotechnology industry
Industry Median: -86.83
vs WBO:ALKB: 26.75
Alk-Abello AS's 5-Year Average Operating Margin % Growth Rate was 41.80% per year.
Alk-Abello AS's Operating Income for the
three
months ended in Mar. 2026 was €76.3 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was €235.0 Mil.
Alk-Abello AS (WBO:ALKB) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Alk-Abello AS Operating Margin % Related Terms
Alk-Abello AS Operating Margin % Historical Data
* Premium members only.
The historical data trend for Alk-Abello AS's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:ALKB vs VRTX, REGN, ALNY: Operating Margin % Comparison
For the Biotechnology subindustry, Alk-Abello AS's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alk-Abello AS Operating Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Alk-Abello AS's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Alk-Abello AS's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Alk-Abello AS's Operating Margin % for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alk-Abello AS (WBO:ALKB) has a Operating Margin % of 32.19% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Alk-Abello AS and its competitors. This is 260% above median its historical median of 8.94. According to the industry distribution chart, Alk-Abello AS ranks #75 out of 944 companies in the Biotechnology industry, placing it in the top 7.9%.
Is Alk-Abello AS's Operating Margin % too high?
Alk-Abello AS's current Operating Margin % of 32.19% is 260% above median its 10-year median of 8.94. Based on the distribution chart, Alk-Abello AS ranks #75 out of 944 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Alk-Abello AS has a GF Score™ of 66/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alk-Abello AS's Operating Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Alk-Abello AS ranks #75 out of 944 companies for Operating Margin %. This places Alk-Abello AS in the top 8% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Biotechnology company?
A good Operating Margin % depends on the Biotechnology industry context. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Alk-Abello AS and its competitors. Alk-Abello AS's current Operating Margin % is 32.19%, which is 260% above median its own 10-year median of 8.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alk-Abello AS stock overvalued right now?
Based on GuruFocus' analysis, Alk-Abello AS (WBO:ALKB) is currently considered Modestly Overvalued. The stock's GF Value™ is €27.26, compared to a current price of €34.22 — trading 25.5% above its estimated fair value. The current Operating Margin % is 32.19%, which is 260% above median its 10-year median of 8.94. Alk-Abello AS's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Alk-Abello AS (WBO:ALKB), the current Operating Margin % is 32.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alk-Abello AS (WBO:ALKB) Overvalued in 2026?
Based on GuruFocus' analysis, Alk-Abello AS stock appears to be overvalued.
The current stock price of €34.22 is trading 25.5% above its estimated GF Value™ of €27.26.
GuruFocus considers Alk-Abello AS to be Modestly Overvalued.
Key valuation signals for WBO:ALKB:
Operating Margin %: 32.19% (260% above median its 10-year median of 8.94)
GF Value™: €27.26 vs. price of €34.22 (25.5% above fair value)
No single metric tells the full story. See the WBO:ALKB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.
66GF Score
Get the complete analysis for WBO:ALKB
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:ALKB has been successfully added to your 
